Michael Nakazawa MD PhD

Heme/Onc fellow - interested in solid onc & tumor biology - @MDAndersonNews

[Elise Nassif Haddad @NassifElise]

💫Poster Board 483 #sarcoma
Superstar @MNakazawa8 and @jalivingston_md presenting work from @MDAndersonNews:
Identification of a subset of DDR deficient #LMS with loss of RNase H2
⚠️therapeutic implications
‼️potentially targetable

[UT MD Anderson @UTMDAnderson]

What are the latest advances in treating sarcoma?

Learn about the findings that our Dr. Neeta Somaiah and MD Anderson experts will be presenting at #ASCO23. https://t.co/sKN1OEWxw9 @NeetaSomaiahMD @APConley77 @MNakazawa8 @ASCO #Sarcoma #EndCancer

[Chijioke Nze MD, MPH @chijioke_nze]

Got to attend my first in person #ASCO2022 with this stellar group! @MDAndersonNews came to represent at the @ConquerCancerFd awards this year! More to come! @MNakazawa8 @patrickreville AmyAn @DrAjlanAlZaki @hjcherng @AndrewJallouk @FasaAgbedia.

[Michael Nakazawa MD PhD @MNakazawa8]

Truly honored! Thank you @ConquerCancerFd @TapCancerOut for this wonderful opportunity!

[Conquer Cancer, the ASCO Foundation @ConquerCancerFd]

We’re proud to support 97 promising physicians with their work to help patients through quality #cancerresearch in clinical #oncology. Meet the 2022 recipients of the Conquer Cancer Young Investigator Awards (YIA)!

[Cancer Discovery @CD_AACR]

Just published! We proudly present "Hallmarks of Cancer: New Dimensions" by Douglas Hanahan, the third update to the seminal series. https://t.co/bSer4maIjF @Ludwig_Cancer

[UT MD Anderson @UTMDAnderson]

The findings of a recent study "indicate that nivolumab plus relatlimab should likely become the new standard of care in first-line advanced melanoma," according to our Dr. Hussein Tawbi: https://t.co/mw0dBx2gsm @GoHealio @HTawbi_MD #ASCO21 #melanoma #EndCancer

[Michael Nakazawa MD PhD @MNakazawa8]

KRASG12C Inhibition with Sotorasib in Advanced Solid Tumors | NEJM https://t.co/7mP47LDJxK

[JAMA @JAMA_current]

Active surveillance for low-risk prostate CA appears comparably safe for Black vs White men in equitable care systems such as @DeptVetAffairs. Further reassurance would be gained from research showing similar outcomes in broader settings @CurtisPettaway1 https://t.co/yDecIlsTUB

[NEJM @NEJM]

In a woman with thyroid cancer expressing an EML4-NTRK3 fusion gene, the cancer had become refractory to radioactive iodine when the capacity of the tumors to take up iodine was lost.

[nature @Nature]

It’s #CRISPR. Emmanuelle Charpentier and Jennifer Doudna ,who pioneered the revolutionary gene-editing technology, are the winners of this year’s #NobelPrize in Chemistry. #NobelPrize2020
https://t.co/I9uqEE41or